223 related articles for article (PubMed ID: 36143828)
1.
Takahashi T; Saito A; Kuronuma K; Nishikiori H; Chiba H
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143828
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
[TBL] [Abstract][Full Text] [Related]
3. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
Jin F; Liu XH; Chen WC; Fan ZL; Wang HL
Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
[TBL] [Abstract][Full Text] [Related]
4. Two pediatric cases of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction of gastric lavage.
Takei H; Ishiwada N; Hishiki H; Takeshita K; Naito S; Endo M; Shimojo N
J Infect Chemother; 2019 Jun; 25(6):477-479. PubMed ID: 30797688
[TBL] [Abstract][Full Text] [Related]
5. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
[TBL] [Abstract][Full Text] [Related]
6. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
[TBL] [Abstract][Full Text] [Related]
7. VV-ECMO combined with prone position ventilation in the treatment of Pneumocystis jirovecii pneumonia: A case report.
Jia L; Zhang Z; Bai Y; Du Q
Medicine (Baltimore); 2022 Jan; 101(1):e28482. PubMed ID: 35029898
[TBL] [Abstract][Full Text] [Related]
8. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
[TBL] [Abstract][Full Text] [Related]
9. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
Tu GW; Ju MJ; Xu M; Rong RM; He YZ; Xue ZG; Zhu TY; Luo Z
Nephrology (Carlton); 2013 Nov; 18(11):736-42. PubMed ID: 24571744
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
Avino LJ; Naylor SM; Roecker AM
Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
[TBL] [Abstract][Full Text] [Related]
11. Case report: new development of fibrosing interstitial lung disease triggered by HIV-related pneumocystis pneumonia.
Suzuki T; Shimoda Y; Teruya K; Gatanaga H; Kikuchi Y; Oka S; Watanabe K
BMC Pulm Med; 2019 Mar; 19(1):65. PubMed ID: 30885173
[TBL] [Abstract][Full Text] [Related]
12. Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?
Chong WH; Saha BK; Chopra A
Infection; 2021 Dec; 49(6):1079-1090. PubMed ID: 34059997
[TBL] [Abstract][Full Text] [Related]
13. Sub-therapeutic trimethoprim and sulfamethoxazole plasma concentrations during continuous venovenous hemofiltration in a patient with COVID-19 and pulmonary
le Noble JLML; Foudraine N; van der Elst KCM; Bouwman S
Int J Clin Pharmacol Ther; 2023 Nov; 61(11):525-530. PubMed ID: 37489071
[TBL] [Abstract][Full Text] [Related]
14. Time to trimethoprim/sulfamethoxazole initiation among patients with rheumatic disease complicated by Pneumocystis jirovecii pneumonia: impact on 90-day mortality.
Song S; Zhang Y; Yu J; Xie C; Chen Y; Zhang X
BMC Infect Dis; 2022 Dec; 22(1):961. PubMed ID: 36575406
[TBL] [Abstract][Full Text] [Related]
15. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for
Awad M; Sierra CM; Mesghali E; Bahjri K
J Oncol Pharm Pract; 2021 Dec; 27(8):1936-1939. PubMed ID: 33307970
[TBL] [Abstract][Full Text] [Related]
16. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia.
Gochi M; Takayanagi N; Ishiguro T; Miyahara Y; Yanagisawa T; Shimizu Y; Sugita Y
Intern Med; 2014; 53(11):1137-41. PubMed ID: 24881737
[TBL] [Abstract][Full Text] [Related]
17.
Viceconte G; Buonomo AR; Lanzardo A; Pinchera B; Zappulo E; Scotto R; Schiano Moriello N; Vargas M; Iacovazzo C; Servillo G; Gentile I;
Infect Dis (Lond); 2021 May; 53(5):382-385. PubMed ID: 33645461
[TBL] [Abstract][Full Text] [Related]
18. Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.
Shimizu Y; Sunaga N; Dobashi K; Fueki M; Fueki N; Makino S; Mori M
BMC Infect Dis; 2009 Apr; 9():47. PubMed ID: 19383170
[TBL] [Abstract][Full Text] [Related]
19. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
Lu YM; Lee YT; Chang HC; Yang HS; Chang CY; Huang CM; Wei J
Transplant Proc; 2017 Oct; 49(8):1893-1898. PubMed ID: 28923644
[TBL] [Abstract][Full Text] [Related]
20. [Concurrent COVID-19 and Pneumocystis Jirovecii Pneumonia in a Patient with Breast Cancer Receiving Adjuvant Dose-Dense Chemotherapy].
Fujii K; Chihara Y; Mishima C; Yamamoto M
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1941-1943. PubMed ID: 36733051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
